Related Experiment Video
Updated: Jun 2, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Adrenal Insufficiency Due to Inhaled Etomidate in Electronic Cigarettes.
Eng-Loon Tng1, Aye Thida Aung2, Yee Sian Tiong3
1Raffles Diabetes and Endocrine Centre, Raffles Hospital, Singapore.
Inhaled etomidate misuse can cause adrenal insufficiency, mimicking rare conditions. This case highlights the importance of suspecting etomidate exposure in unexplained adrenal insufficiency, with symptoms resolving after cessation.
Area of Science:
- Endocrinology
- Toxicology
Background:
- A 33-year-old female presented with recurrent fainting and was diagnosed with primary adrenal insufficiency.
- Initial investigations revealed no typical signs of adrenal disorders, and she had no history of steroid use.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Inhalational Anesthetics: Overview
Chronic Obstructive Pulmonary Disease II: Emphysema
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
